LessTests
Software Solutions for Optimizing COVID-19 Diagnostics
Company Overview
Snapshot
Founded in March 2020 by Ruth Polachek and Tsvika Vagman, LessTests operated with 1–10 employees. The company ceased operations in December 2022.
Business overview
LessTests developed software solutions aimed at optimizing COVID-19 diagnostic testing. The company's core technology involved multi-variant algorithms designed to analyze and enhance the throughput and protocols of COVID-19 polymerase-chain-reaction diagnostics. Serving virological labs globally, LessTests operated within the Health Tech & Life Sciences sector, specifically focusing on Digital Medical Diagnostics and Digital Healthcare.
Strategic signal
In September 2020, LessTests gained attention for its single-step pooling software, which was designed to significantly multiply COVID-19 testing capacity. This development highlighted the company's innovative approach to addressing the pandemic's diagnostic challenges and signaled its potential to enhance global testing infrastructure.
Log in to access full profile ›Company Intelligence Q&A
- What was the primary focus of LessTests?
- LessTests focused on developing software solutions to optimize COVID-19 diagnostic tests, aiming to make them more widely available and efficient globally.
- When was LessTests founded and by whom?
- LessTests was founded in March 2020 by co-founders Ruth Polachek and Tsvika Vagman.
- What was the operational status of LessTests?
- LessTests ceased to operate in December 2022, transitioning to a non-active status.
- What was a key technological innovation from LessTests?
- In September 2020, LessTests developed single-step pooling software designed to multiply COVID-19 testing capacity, enhancing diagnostic throughput and protocols for virological labs.
- Which company participated in LessTests' funding round?
- In October 2020, Neo Pharm participated in a Seed funding round for LessTests.